THE EFFICACY AND COST-EFFECTIVENESS OF HYDROXYCHLOROQUINE, SULFASALAZINE, METHOTREXATE TRIPLE THERAPY IN PREVENTING RELAPSE OF RHEUMATOID ARTHRITIS

被引：1
|
作者：
Zhao, J. [1 ]
Zhou, W. [1 ]
Wu, Y. [2 ]
Ji, P. [2 ]
Yan, X. [2 ]
Yang, L. [3 ]
Zhang, Z. [1 ]
机构：
[1] Peking Univ, Rheumatol & Immunol Dept, Hosp 1, Beijing, Peoples R China
[2] Peking Univ Clin Res Inst PUCRI, Beijing, Peoples R China
[3] Peking Univ, Sch Publ Hlth, Beijing, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.1926
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0143
引用
收藏
页码：651 / 651
页数：1
相关论文
共 50 条
  • [1] Triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine in patients with rheumatoid arthritis
    O'Dell, JR
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1998, 24 (03) : 465 - +
  • [2] Efficacy, safety, and cost-effectiveness of triple therapy in preventing relapse in rheumatoid arthritis: A randomized controlled trial (ESCoRT study)
    Zhao, Juan
    Zhou, Wei
    Wu, Yangfeng
    Yan, Xiaoyan
    Yang, Li
    Zhang, Zhuoli
    [J]. CHINESE MEDICAL JOURNAL, 2022, 135 (18) : 2200 - 2209
  • [3] Efficacy, safety, and cost-effectiveness of triple therapy in preventing relapse in rheumatoid arthritis: A randomized controlled trial (ESCoRT study)
    Zhao Juan
    Zhou Wei
    Wu Yangfeng
    Yan Xiaoyan
    Yang Li
    Zhang Zhuoli
    [J]. 中华医学杂志(英文版), 2022, 135 (18)
  • [4] Cost-Effectiveness of Methotrexate and Sulfasalazine in Rheumatoid Arthritis: A Comparative Study
    Bhatt, K.
    Girish, K.
    Pundarikaksha, H. P.
    Tamboli, T.
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 : S54 - S54
  • [5] The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study)
    Juan Zhao
    Wei Zhou
    Yangfeng Wu
    Ping Ji
    Li Yang
    Xiaoyan Yan
    Zhuoli Zhang
    [J]. BMC Medical Informatics and Decision Making, 21
  • [6] The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study)
    Zhao, Juan
    Zhou, Wei
    Wu, Yangfeng
    Ji, Ping
    Yang, Li
    Yan, Xiaoyan
    Zhang, Zhuoli
    [J]. BMC MEDICAL INFORMATICS AND DECISION MAKING, 2021, 21 (01)
  • [7] Retention of triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine compared to combination methotrexate and leflunomide in rheumatoid arthritis
    Bhavsar, Sankalp Virendrakumar
    Movahedi, Mohammad
    Cesta, Angela
    Pope, Janet E.
    Bombardier, Claire
    [J]. JOINT BONE SPINE, 2024, 91 (04)
  • [8] Comparison of efficacy and tolerability of triple combination therapy (methotrexate plus sulfasalazine plus hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis
    Gubar, E. E.
    Bochkova, A. G.
    Bunchuk, N., V
    [J]. TERAPEVTICHESKII ARKHIV, 2008, 80 (05): : 25 - 30
  • [9] Cost-Effectiveness of Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis
    Jalal, Hawre
    O'Dell, James R.
    Bridges, S. Louis, Jr.
    Cofield, Stacey
    Curtis, Jeffrey R.
    Mikuls, Ted R.
    Moreland, Larry W.
    Michaud, Kaleb
    [J]. ARTHRITIS CARE & RESEARCH, 2016, 68 (12) : 1751 - 1757
  • [10] EFFICACY OF COMBINATION THERAPY OF METHOTREXATE WITH HYDROXYCHLOROQUINE OR SULFASALAZINE IN RHEUMATOID ARTHRITIS PATIENTS IN KUMAON REGION: A COMPARATIVE STUDY
    Bharat, Suyash
    Srivastava, Bhavana
    Singh, Paramjeet
    Bhardwaj, Reena
    Gaur, Sanjay
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (51): : 3403 - 3407
12345